Fundación Teófilo Hernando, CRO in Spain of a pivotal clinical study with the first medica... 03/10/2024 Healthcare Access to innovation Personalized medicine The international study involves the Complexo Hospitalario Universitario de A Coruña in Spain and two other sites in... Partners - Fundación Teófilo Hernando (FTH)
Biotechnology plays a crucial role in the latest advances against Alzheimer's 21/09/2024 Healthcare Innovative drugs Personalized medicine Advanced therapies Biotechnology is behind every medication being tested and eventually approved, making its contribution the key factor... AseBio
Biotechnology plays a crucial role in the latest advances against Alzheimer's 21/09/2024 Nearly two decades ago, the first group of compounds to treat Alzheimer's disease were approved, but they do not stop... AseBio
Biotechnology revolutionizes the diagnosis and treatment of lymphoma, the seventh most com... 15/09/2024 Healthcare Rare diseases Personalized medicine Advanced therapies It is estimated that in 2024, around 12,400 new cases of lymphoma will be diagnosed in Spain, the majority... AseBio
Biotechnology revolutionizes the diagnosis and treatment of lymphoma, the seventh most com... 15/09/2024 There are more than 40 types of lymphomas that can generally be grouped into two major subgroups: Hodgkin lymphoma and... AseBio
Biological Sex Differences in Health: Challenges and Opportunities for Personalised Medici... 10/09/2024 Healthcare Personalized medicine Biological sex should be considered as a variable in all health-related biomedical research. Partners - GENESIS Biomed
NLRP3: From Scientific Curiosity to Therapeutic Efficacy 04/09/2024 Healthcare Personalized medicine Advanced therapies Joaquín Gómez Moya, executive president of Viva in Vitro, explains in this forum the important role of the NLRP3... Partners - VIVA IN VITRO
New €1.3 million round for Viva in Vitro brings it over €3 million investment to fight sep... 09/07/2024 Healthcare Personalized medicine In less than 3 years, the Spanish biotech company has attracted the confidence of investors and international medical... Partners - VIVA IN VITRO
Oryzon selected as Associated Partner in the first Important Project of Common European In... 29/05/2024 Healthcare Access to innovation Drug discovery Rare diseases Innovative drugs Personalized medicine Financing Commission has approved up to €1 billion of State aid by six Member States: Belgium, France, Hungary, Italy, Slovakia... Partners - Oryzon Genomics
Atlas Molecular Pharma successfully completes phase one in humans of its treatment for Con... 28/05/2024 Healthcare Access to innovation Drug discovery Rare diseases Innovative drugs Personalized medicine The final results of ATL-001, the biotech company's lead candidate, have shown that it is able to stabilize UROIIIS and... Partners - Inveready
